Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Karyopharm Therapeutics Inc banner

Karyopharm Therapeutics Inc
NASDAQ:KPTI

Watchlist Manager
Karyopharm Therapeutics Inc Logo
Karyopharm Therapeutics Inc
NASDAQ:KPTI
Watchlist
Price: 9.5 USD 5.56% Market Closed
Market Cap: $215.3m
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Gross Profit
Loading...
Operating Income
Loading...
Pre-Tax Income
Loading...
Net Income
Loading...

Wall St Price Targets

KPTI Price Targets Summary
Karyopharm Therapeutics Inc

Wall Street analysts forecast KPTI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for KPTI is 13.67 USD with a low forecast of 7.07 USD and a high forecast of 16.8 USD.

KPTI Lowest Forecast
7.07 USD
-26% Downside
KPTI Average Forecast
13.67 USD
44% Upside
KPTI Highest Forecast
16.8 USD
77% Upside
Lowest Forecast
Price Target
7.07 USD
26% Downside
Average Forecast
Price Target
13.67 USD
44% Upside
Highest Forecast
Price Target
16.8 USD
77% Upside
Karyopharm Therapeutics Inc Competitors:
Price Targets
ZNTL
Zentalis Pharmaceuticals Inc
77% Upside
ZNTL
Zentalis Pharmaceuticals Inc
77% Upside

Revenue
Forecast

53% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
53% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 53%. The projected CAGR for the next 3 years is 17%.

What are analyst estimates?

Gross Profit
Forecast

N/A
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

The compound annual growth rate for Gross Profit over the next 3 years is 15%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

What are analyst estimates?

See Also

Summary
KPTI intrinsic value, competitors valuation, and company profile.
DCF Valuation
KPTI stock valuation using Discount Cash Flow valuation method.
Relative Valuation
KPTI stock valuation using valuation multiples.
Wall St Estimates
KPTI price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
KPTI stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Karyopharm Therapeutics Inc listings:
F • EUR
25K
 SWB • EUR
25K
 F • EUR
25K0
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is KPTI's stock price target?
Price Target
13.67 USD

According to Wall Street analysts, the average 1-year price target for KPTI is 13.67 USD with a low forecast of 7.07 USD and a high forecast of 16.8 USD.

What is the Revenue forecast for Karyopharm Therapeutics Inc?
Projected CAGR
17%

Over the last 13 years, the compound annual growth rate for Revenue has been 53%. The projected CAGR for the next 3 years is 17%.

What is the Gross Profit forecast for Karyopharm Therapeutics Inc?
Projected CAGR
15%

The compound annual growth rate for Gross Profit over the next 3 years is 15%.

Back to Top
ALPHA SPREAD
Follow us
Join 343,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett